Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Open Label Trial to Investigate the Efficacy and Safety of a Single Oral Dose of 1.0 mg/kg Macimorelin Acetate as Growth Hormone Stimulation Test (GHST) in Pediatric Patients With Suspected Growth Hormone Deficiency (GHD)

NCT04786873 is registered in ClinicalTrials.gov with AEterna Zentaris as lead sponsor.

NCT NCT04786873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04786873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Open Label Trial to Investigate the Efficacy and Safety of a Single Oral Dose of 1.0 mg/kg Macimorelin Acetate as Growth Hormone Stimulation Test (GHST) in Pediatric Patients With Suspected Growth Hormone Deficiency (GHD)
Lead sponsor
AEterna Zentaris
Phase
Phase 3
Overall status
Completed
Start date
November 16, 2021
Completion date
June 13, 2024
Enrollment
101 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone deficiency